X4 Pharmaceuticals

Price & Volume

Stats

52W Range	$0.18-$1.39
Market Cap	$33.1M
Shares Short	8M

Financials

Revenue (12 Mos)	$2.5M
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$1.7M
Diluted EPS	-$0.19

News

Yahoo Finance • 26 days ago

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Yahoo Finance • last month

X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2024 Financial Results and Host a Conference Call and Webcast on March 25, 2025

Yahoo Finance • 2 months ago

X4 Pharmaceuticals and taiba rare Announce Exclusive Agreement for the Distribution and Commercialization of XOLREMDI® (mavorixafor) in WHIM Syndrome in Select Middle East Countries

Yahoo Finance • 2 months ago

X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia

About

CEO	Dr. Paula Ragan Ph.D.
CFO	Mr. Adam S. Mostafa
Address	61 North Beacon Street, Boston, MA, United States, 02134
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	143